查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1987015

醫療保健領域人工智慧 (AI) 市場到 2035 年的分析和預測：按類型、產品類型、技術、組件、應用、部署模式、最終用戶、解決方案和交付模式分類。

Artificial Intelligence in Healthcare Market Analysis and Forecast to 2035: Type, Product, Technology, Component, Application, Deployment, End User, Solutions, Mode
出版日期: | 出版商: Global Insight Services | 英文 350 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球醫療保健領域的人工智慧 (AI) 市場預計將從 2025 年的 146 億美元成長到 2035 年的 1,027 億美元，複合年成長率 (CAGR) 為 21.8%。這一成長主要得益於機器學習技術的進步、醫療數據量的不斷成長、對個人化醫療的需求以及人工智慧在簡化診斷和患者照護方面發揮的作用。醫療保健領域的人工智慧市場由幾個關鍵細分市場構成，其中機器學習約佔 35% 的市場佔有率，其次是自然語言處理（25%）和機器人流程自動化 (RPA)（20%）。主要應用包括診斷、個人化醫療和醫院管理系統。該市場集中度適中，由少數主要企業和眾多中小企業組成，形成了一個多元化的生態系統。實施數據分析表明，在人工智慧驅動的診斷工具和患者管理系統日益普及的推動下，醫療機構中人工智慧的部署數量正在不斷增加。

競爭格局由全球性和區域性公司共同構成，其中科技巨頭和醫療人工智慧專家扮演著重要角色。人工智慧演算法的不斷進步及其與現有醫療系統的融合推動了創新水準的顯著提高。為拓展技術能力和市場涵蓋範圍，併購和策略聯盟屢見不鮮。一個值得關注的趨勢是，科技公司與醫療服務提供者攜手合作，共同開發人工智慧驅動的解決方案，以改善患者預後並提升營運效率。

市場區隔
類型 機器學習、自然語言處理、電腦視覺、機器人技術及其他
產品 基於人工智慧的軟體、基於人工智慧的硬體、基於人工智慧的服務等等。
科技 深度學習、預測分析、語音辨識、影像識別等等。
成分 軟體、硬體、服務及其他
目的 臨床試驗、機器人輔助手術、虛擬護理助理、行政工作流程支援、詐欺檢測、診斷和治療、病患管理等。
實作方法 雲端部署、本地部署、混合部署及其他
最終用戶 醫院、製藥公司、研究機構、醫療保健提供者及其他
解決方案 患者數據和風險分析、醫學影像和診斷、生活方式管理和監測、虛擬助理等。
提供的表格 B2B、B2C、其他

醫療保健領域人工智慧市場的「類型」細分市場主要受機器學習和自然語言處理技術日益普及的驅動。機器學習因其能夠分析複雜資料集並提高診斷準確率而成為主流。另一方面，自然語言處理對於管理臨床記錄中的非結構化資料至關重要。這些技術對於改善患者照護和營運效率至關重要，醫院和研究機構對利用人工智慧進行預測分析和個人化醫療的需求十分旺盛。

在技​​術領域，深度學習和電腦視覺處於領先地位，這主要得益於其在醫學影像和診斷領域的應用。深度學習演算法擅長模式識別，能夠更準確地解讀醫學影像，這在放射學和病理學中至關重要。電腦視覺也擴大應用於外科手術輔助和病患生命徵象監測。人工智慧演算法的不斷進步以及人工智慧與物聯網設備的整合正在推動其發展，尤其是在擁有完善醫療基礎設施的已開發地區。

在應用領域，診斷和個人化醫療方面取得了顯著進展。診斷是人工智慧應用的一個重要分支，人工智慧提高了疾病檢測的速度和準確性，尤其是在腫瘤學和心臟病學領域。個人化醫療正蓬勃發展，這得益於人工智慧能夠根據個人基因譜最佳化治療方法。這種需求源於對精準醫療解決方案的需求以及對預防醫學日益成長的重視，而病患資料的可用性提高和先進分析工具的普及也為此提供了支持。

在終端用戶領域，醫院和醫療機構是人工智慧應用的主要推動者。醫院利用人工智慧透過增強決策能力和自動化工作流程來改善病患預後、簡化營運流程並降低成本。醫療機構則利用人工智慧進行病患管理和治療方案。醫療保健產業數位轉型趨勢以及提供以價值為導向的醫療服務的壓力，正促使這些終端用戶對人工智慧技術進行大量投資。

組件領域以軟體解決方案為主，這些解決方案構成了醫療保健領域人工智慧應用的基礎。人工智慧軟體平台對於資料管理、演算法開發以及在臨床環境中部署人工智慧模型至關重要。 GPU 和處理器等硬體組件對於滿足人工智慧系統的運算需求也至關重要。隨著人工智慧模型日益複雜，即時數據處理的需求不斷成長，對軟體和硬體的投資都在推動市場需求，而具有可擴展性和柔軟性的雲端解決方案也越來越受歡迎。

區域概覽

北美：北美醫療保健領域的人工智慧市場高度成熟，這得益於其強大的技術基礎設施和大量的研發投入。美國在該地區處於領先地位，尤其專注於精準醫療和數位健康解決方案。生物技術、製藥和醫療設備等關鍵產業正在加速人工智慧的整合，以改善病患療效和提升營運效率。

歐洲：歐洲市場發展較成熟，英國、德國和法國等國在醫療保健領域引領人工智慧的應用。該地區受益於完善的法規結構和對數位化醫療轉型的高度重視。推動需求的關鍵產業包括醫療保健IT、診斷和遠端醫療，這些產業正利用人工智慧技術來改善醫療服務和患者照護。

亞太地區：人工智慧醫療應用在亞太地區正快速發展，中國、日本和印度等國家處於領先地位。該市場的特點是對人工智慧Start-Ups的投資不斷增加，以及政府主導的旨在加強醫療基礎設施的各項舉措。關鍵產業包括醫院管理、診斷和穿戴式技術，人工智慧正被用於應對龐大人口和多樣化醫療需求帶來​​的挑戰。

拉丁美洲：拉丁美洲的醫療人工智慧市場仍處於起步階段，巴西和墨西哥貢獻顯著。人工智慧技術正逐步引入該地區，以提高醫療服務的可及性和效率。關鍵產業包括遠距遠端醫療、醫療資訊科技和診斷。這是因為人工智慧解決方案正被部署用於克服區域醫療資源不平衡和資源限制等問題。

中東和非洲：中東和非洲地區正在崛起為領先的人工智慧醫療市場，其中阿拉伯聯合大公國和南非處於領先地位。政府主導的醫療創新措施和投資是推動該市場發展的主要動力。關鍵產業包括醫院管理和遠端醫療，人工智慧正被應用於這些領域，以改善偏遠地區的醫療服務並提高整個系統的效率。

主要趨勢和促進因素

趨勢一：人工智慧在診斷影像的應用

人工智慧在診斷影像領域的應用正在革新醫療產業，顯著提升醫學影像的準確性和效率。人工智慧演算法正被擴大用於分析複雜的影像數據，從而實現對癌症、心血管疾病和神經系統疾病等病症更快、更準確的診斷。這一趨勢的驅動力源於對更先進診斷工具的需求、影像檢查數量的不斷成長以及減少放射學中人為錯誤的迫切需求。

兩大趨勢：個人化醫療和人工智慧

人工智慧在推進個人化醫療方面發揮著至關重要的作用，它能夠分析大規模資料集，識別模式並預測個體對治療的反應。這一趨勢的驅動力源於基因組數據的日益豐富以及對個人化治療方案的需求，這些方案需充分考慮個體的基因組成、生活方式和環境因素。人工智慧驅動的個人化醫療可望透過改善患者療效、減少藥物副作用和最佳化治療方案，徹底改變醫療保健的提供方式。

三大趨勢：人工智慧驅動的虛擬健康助理

人工智慧驅動的虛擬健康助理正日益普及，使患者能夠全天候獲取醫療資訊和支援。這些數位助理利用自然語言處理和機器學習技術，提供個人化的健康建議、安排預約並管理慢性疾病。這一趨勢的驅動力源於人們對便利、經濟的醫療保健解決方案日益成長的需求，以及遠距遠端醫療和遠端患者監護技術的廣泛應用。

四大趨勢：人工智慧醫療應用監管的演變

監管機構日益認知到人工智慧在醫療保健領域的潛力，並致力於建立相關框架，以確保人工智慧技術的安全有效應用。這一趨勢包括制定人工智慧應用指南和標準，以應對資料隱私、演算法透明度和患者安全等挑戰。監管方面的進展對於促進創新至關重要，同時也能確保人工智慧解決方案符合嚴格的醫療保健標準並且廣泛應用。

五大趨勢：人工智慧在藥物發現與研發的應用

人工智慧正在變革藥物發現和開發流程，顯著縮短新藥上市的時間並降低成本。機器學習演算法正被用於識別有前景的候選藥物、預測其療效並最佳化臨床試驗設計。這一趨勢的驅動力源自於製藥業加速研發進程和提高成功率的需求。人工智慧分析大量資料集並從中產生洞見的能力，已被證明在尋找新型療法和個人化治療方法方面具有不可估量的價值。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制因素
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章：細分市場分析

  • 市場規模及預測：依類型
    • 機器學習
    • 自然語言處理
    • 電腦視覺
    • 機器人技術
    • 其他
  • 市場規模及預測：依產品分類
    • 基於人工智慧的軟體
    • 人工智慧驅動的硬體
    • 基於人工智慧的服務
    • 其他
  • 市場規模及預測：依技術分類
    • 深度學習
    • 預測分析
    • 語音辨識
    • 影像識別
    • 其他
  • 市場規模及預測：依組件分類
    • 軟體
    • 硬體
    • 服務
    • 其他
  • 市場規模及預測：依應用領域分類
    • 臨床試驗
    • 機器人輔助手術
    • 虛擬護理助理
    • 支援行政工作流程
    • 詐欺偵測
    • 診斷和治療
    • 病患管理
    • 其他
  • 市場規模及預測：依最終用戶分類
    • 醫院
    • 製藥公司
    • 研究所
    • 醫療保健提供者
    • 其他
  • 市場規模及預測：依市場細分
    • 基於雲端的
    • 現場
    • 混合
    • 其他
  • 市場規模及預測：按解決方案分類
    • 患者數據和風險分析
    • 醫學影像診斷
    • 生活方式管理和監測
    • 虛擬助手
    • 其他
  • 市場規模及預測：以交付方式分類
    • B2B
    • B2C
    • 其他

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地區
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 供需差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 監管概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要企業的策略

第8章：公司簡介

  • IBM
  • Microsoft
  • Google
  • Amazon
  • Siemens Healthineers
  • Philips Healthcare
  • GE Healthcare
  • Medtronic
  • Cerner Corporation
  • Epic Systems Corporation
  • NVIDIA
  • Intel Corporation
  • Nuance Communications
  • Allscripts Healthcare Solutions
  • Zebra Medical Vision
  • iCarbonX
  • Tempus Labs
  • PathAI
  • Butterfly Network
  • Viz.ai

第9章 關於我們

簡介目錄
Product Code: GIS20011

The global Artificial Intelligence in Healthcare Market is projected to grow from $14.6 billion in 2025 to $102.7 billion by 2035, at a compound annual growth rate (CAGR) of 21.8%. Growth is driven by advancements in machine learning, increasing healthcare data, personalized medicine demand, and AI's role in diagnostics and patient care efficiency. The Artificial Intelligence in Healthcare Market is characterized by several leading segments, with machine learning holding approximately 35% market share, followed by natural language processing at 25%, and robotic process automation at 20%. Key applications include diagnostics, personalized medicine, and hospital management systems. The market is moderately consolidated, with a few dominant players and numerous smaller firms contributing to a diverse ecosystem. Volume insights indicate a growing number of AI installations in healthcare facilities, driven by the increasing adoption of AI-powered diagnostic tools and patient management systems.

The competitive landscape features a mix of global and regional players, with significant contributions from technology giants and specialized healthcare AI firms. The degree of innovation is high, with continuous advancements in AI algorithms and integration with existing healthcare systems. Mergers and acquisitions, along with strategic partnerships, are prevalent as companies seek to expand their technological capabilities and market reach. Notable trends include collaborations between tech companies and healthcare providers to develop AI-driven solutions that enhance patient outcomes and operational efficiency.

Market Segmentation
TypeMachine Learning, Natural Language Processing, Computer Vision, Robotics, Others
ProductAI-based Software, AI-based Hardware, AI-based Services, Others
TechnologyDeep Learning, Predictive Analytics, Speech Recognition, Image Recognition, Others
ComponentSoftware, Hardware, Services, Others
ApplicationClinical Trials, Robot-Assisted Surgery, Virtual Nursing Assistants, Administrative Workflow Assistance, Fraud Detection, Diagnosis and Treatment, Patient Management, Others
DeploymentCloud-Based, On-Premises, Hybrid, Others
End UserHospitals, Pharmaceutical Companies, Research Laboratories, Healthcare Providers, Others
SolutionsPatient Data & Risk Analytics, Medical Imaging & Diagnostics, Lifestyle Management & Monitoring, Virtual Assistants, Others
ModeB2B, B2C, Others

The Type segment in the AI in Healthcare market is primarily driven by the increasing adoption of machine learning and natural language processing technologies. Machine learning dominates due to its ability to analyze complex datasets and improve diagnostic accuracy, while natural language processing is crucial for managing unstructured data in clinical documentation. These technologies are pivotal in enhancing patient care and operational efficiency, with significant demand from hospitals and research institutions seeking to leverage AI for predictive analytics and personalized medicine.

In the Technology segment, deep learning and computer vision are at the forefront, driven by their applications in medical imaging and diagnostics. Deep learning algorithms excel in pattern recognition, enabling more accurate interpretation of medical images, which is critical in radiology and pathology. Computer vision is increasingly used for surgical assistance and monitoring patient vitals. The ongoing advancements in AI algorithms and the integration of AI with IoT devices are propelling growth, particularly in developed regions with advanced healthcare infrastructure.

The Application segment sees significant traction in the areas of diagnostics and personalized medicine. Diagnostics is the leading subsegment, as AI enhances the speed and accuracy of disease detection, particularly in oncology and cardiology. Personalized medicine is gaining momentum with AI's ability to tailor treatments based on individual genetic profiles. The demand is driven by the need for precision healthcare solutions and the growing emphasis on preventive care, supported by the increasing availability of patient data and advanced analytics tools.

Within the End User segment, hospitals and healthcare providers are the primary drivers of AI adoption. Hospitals leverage AI to improve patient outcomes, streamline operations, and reduce costs through enhanced decision-making and workflow automation. Healthcare providers use AI for patient management and treatment planning. The trend towards digital transformation in healthcare, coupled with the pressure to deliver value-based care, is encouraging these end users to invest heavily in AI technologies.

The Component segment is dominated by software solutions, which form the backbone of AI applications in healthcare. AI software platforms are essential for data management, algorithm development, and deployment of AI models in clinical settings. Hardware components, such as GPUs and processors, are also critical, supporting the computational needs of AI systems. The increasing complexity of AI models and the need for real-time data processing are driving investments in both software and hardware, with cloud-based solutions gaining popularity for their scalability and flexibility.

Geographical Overview

North America: The North American AI in healthcare market is highly mature, driven by robust technological infrastructure and significant investment in R&D. The United States leads the region, with a strong focus on precision medicine and digital health solutions. Key industries include biotechnology, pharmaceuticals, and medical devices, which are increasingly integrating AI to enhance patient outcomes and operational efficiency.

Europe: Europe exhibits moderate market maturity, with countries like the UK, Germany, and France spearheading AI adoption in healthcare. The region benefits from supportive regulatory frameworks and a focus on digital health transformation. Key industries driving demand include healthcare IT, diagnostics, and telemedicine, as AI technologies are leveraged to improve healthcare delivery and patient care.

Asia-Pacific: The Asia-Pacific region is experiencing rapid growth in AI healthcare applications, with countries like China, Japan, and India leading the charge. The market is characterized by increasing investments in AI startups and government initiatives to enhance healthcare infrastructure. Key industries include hospital management, diagnostics, and wearable technology, as AI is utilized to address the challenges of large populations and diverse healthcare needs.

Latin America: The Latin American AI in healthcare market is in the nascent stage, with Brazil and Mexico being notable contributors. The region is gradually adopting AI technologies to improve healthcare accessibility and efficiency. Key industries include telemedicine, healthcare IT, and diagnostics, as AI solutions are implemented to overcome regional healthcare disparities and resource constraints.

Middle East & Africa: The Middle East & Africa region is emerging in the AI healthcare market, with the UAE and South Africa at the forefront. The market is driven by government initiatives and investments in healthcare innovation. Key industries include hospital management and telemedicine, as AI is deployed to enhance healthcare delivery in remote areas and improve overall system efficiency.

Key Trends and Drivers

Trend 1 Title: Integration of AI in Diagnostic Imaging

The integration of artificial intelligence in diagnostic imaging is revolutionizing the healthcare industry by enhancing the accuracy and efficiency of medical imaging. AI algorithms are increasingly being used to analyze complex imaging data, enabling faster and more precise diagnosis of conditions such as cancer, cardiovascular diseases, and neurological disorders. This trend is driven by the need for improved diagnostic tools, the growing volume of imaging procedures, and the demand for reducing human error in radiology.

Trend 2 Title: Personalized Medicine and AI

AI is playing a crucial role in advancing personalized medicine by enabling the analysis of large datasets to identify patterns and predict individual responses to treatments. This trend is fueled by the increasing availability of genomic data and the need for tailored therapeutic approaches that consider an individual's genetic makeup, lifestyle, and environment. AI-driven personalized medicine is expected to improve patient outcomes, reduce adverse drug reactions, and optimize treatment plans, thereby transforming healthcare delivery.

Trend 3 Title: AI-Powered Virtual Health Assistants

The adoption of AI-powered virtual health assistants is on the rise, providing patients with 24/7 access to healthcare information and support. These digital assistants leverage natural language processing and machine learning to offer personalized health advice, schedule appointments, and manage chronic conditions. This trend is driven by the growing demand for convenient and cost-effective healthcare solutions, as well as the increasing use of telemedicine and remote patient monitoring technologies.

Trend 4 Title: Regulatory Advancements in AI Healthcare Applications

Regulatory bodies are increasingly recognizing the potential of AI in healthcare and are working towards creating frameworks that ensure the safe and effective use of AI technologies. This trend involves the development of guidelines and standards for AI applications, addressing issues such as data privacy, algorithm transparency, and patient safety. Regulatory advancements are crucial for fostering innovation while ensuring that AI solutions meet stringent healthcare standards and gain widespread adoption.

Trend 5 Title: AI in Drug Discovery and Development

AI is transforming the drug discovery and development process by significantly reducing the time and cost associated with bringing new drugs to market. Machine learning algorithms are being used to identify potential drug candidates, predict their efficacy, and optimize clinical trial designs. This trend is driven by the pharmaceutical industry's need to accelerate R&D processes and improve success rates. AI's ability to analyze vast datasets and generate insights is proving invaluable in the quest for novel therapeutics and personalized treatment options.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Technology
  • 2.4 Key Market Highlights by Component
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Deployment
  • 2.8 Key Market Highlights by Solutions
  • 2.9 Key Market Highlights by Mode

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Machine Learning
    • 4.1.2 Natural Language Processing
    • 4.1.3 Computer Vision
    • 4.1.4 Robotics
    • 4.1.5 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 AI-based Software
    • 4.2.2 AI-based Hardware
    • 4.2.3 AI-based Services
    • 4.2.4 Others
  • 4.3 Market Size & Forecast by Technology (2020-2035)
    • 4.3.1 Deep Learning
    • 4.3.2 Predictive Analytics
    • 4.3.3 Speech Recognition
    • 4.3.4 Image Recognition
    • 4.3.5 Others
  • 4.4 Market Size & Forecast by Component (2020-2035)
    • 4.4.1 Software
    • 4.4.2 Hardware
    • 4.4.3 Services
    • 4.4.4 Others
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Clinical Trials
    • 4.5.2 Robot-Assisted Surgery
    • 4.5.3 Virtual Nursing Assistants
    • 4.5.4 Administrative Workflow Assistance
    • 4.5.5 Fraud Detection
    • 4.5.6 Diagnosis and Treatment
    • 4.5.7 Patient Management
    • 4.5.8 Others
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Hospitals
    • 4.6.2 Pharmaceutical Companies
    • 4.6.3 Research Laboratories
    • 4.6.4 Healthcare Providers
    • 4.6.5 Others
  • 4.7 Market Size & Forecast by Deployment (2020-2035)
    • 4.7.1 Cloud-Based
    • 4.7.2 On-Premises
    • 4.7.3 Hybrid
    • 4.7.4 Others
  • 4.8 Market Size & Forecast by Solutions (2020-2035)
    • 4.8.1 Patient Data & Risk Analytics
    • 4.8.2 Medical Imaging & Diagnostics
    • 4.8.3 Lifestyle Management & Monitoring
    • 4.8.4 Virtual Assistants
    • 4.8.5 Others
  • 4.9 Market Size & Forecast by Mode (2020-2035)
    • 4.9.1 B2B
    • 4.9.2 B2C
    • 4.9.3 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Technology
      • 5.2.1.4 Component
      • 5.2.1.5 Application
      • 5.2.1.6 End User
      • 5.2.1.7 Deployment
      • 5.2.1.8 Solutions
      • 5.2.1.9 Mode
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Technology
      • 5.2.2.4 Component
      • 5.2.2.5 Application
      • 5.2.2.6 End User
      • 5.2.2.7 Deployment
      • 5.2.2.8 Solutions
      • 5.2.2.9 Mode
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Technology
      • 5.2.3.4 Component
      • 5.2.3.5 Application
      • 5.2.3.6 End User
      • 5.2.3.7 Deployment
      • 5.2.3.8 Solutions
      • 5.2.3.9 Mode
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Technology
      • 5.3.1.4 Component
      • 5.3.1.5 Application
      • 5.3.1.6 End User
      • 5.3.1.7 Deployment
      • 5.3.1.8 Solutions
      • 5.3.1.9 Mode
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Technology
      • 5.3.2.4 Component
      • 5.3.2.5 Application
      • 5.3.2.6 End User
      • 5.3.2.7 Deployment
      • 5.3.2.8 Solutions
      • 5.3.2.9 Mode
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Technology
      • 5.3.3.4 Component
      • 5.3.3.5 Application
      • 5.3.3.6 End User
      • 5.3.3.7 Deployment
      • 5.3.3.8 Solutions
      • 5.3.3.9 Mode
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Technology
      • 5.4.1.4 Component
      • 5.4.1.5 Application
      • 5.4.1.6 End User
      • 5.4.1.7 Deployment
      • 5.4.1.8 Solutions
      • 5.4.1.9 Mode
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Technology
      • 5.4.2.4 Component
      • 5.4.2.5 Application
      • 5.4.2.6 End User
      • 5.4.2.7 Deployment
      • 5.4.2.8 Solutions
      • 5.4.2.9 Mode
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Technology
      • 5.4.3.4 Component
      • 5.4.3.5 Application
      • 5.4.3.6 End User
      • 5.4.3.7 Deployment
      • 5.4.3.8 Solutions
      • 5.4.3.9 Mode
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Technology
      • 5.4.4.4 Component
      • 5.4.4.5 Application
      • 5.4.4.6 End User
      • 5.4.4.7 Deployment
      • 5.4.4.8 Solutions
      • 5.4.4.9 Mode
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Technology
      • 5.4.5.4 Component
      • 5.4.5.5 Application
      • 5.4.5.6 End User
      • 5.4.5.7 Deployment
      • 5.4.5.8 Solutions
      • 5.4.5.9 Mode
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Technology
      • 5.4.6.4 Component
      • 5.4.6.5 Application
      • 5.4.6.6 End User
      • 5.4.6.7 Deployment
      • 5.4.6.8 Solutions
      • 5.4.6.9 Mode
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Technology
      • 5.4.7.4 Component
      • 5.4.7.5 Application
      • 5.4.7.6 End User
      • 5.4.7.7 Deployment
      • 5.4.7.8 Solutions
      • 5.4.7.9 Mode
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Technology
      • 5.5.1.4 Component
      • 5.5.1.5 Application
      • 5.5.1.6 End User
      • 5.5.1.7 Deployment
      • 5.5.1.8 Solutions
      • 5.5.1.9 Mode
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Technology
      • 5.5.2.4 Component
      • 5.5.2.5 Application
      • 5.5.2.6 End User
      • 5.5.2.7 Deployment
      • 5.5.2.8 Solutions
      • 5.5.2.9 Mode
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Technology
      • 5.5.3.4 Component
      • 5.5.3.5 Application
      • 5.5.3.6 End User
      • 5.5.3.7 Deployment
      • 5.5.3.8 Solutions
      • 5.5.3.9 Mode
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Technology
      • 5.5.4.4 Component
      • 5.5.4.5 Application
      • 5.5.4.6 End User
      • 5.5.4.7 Deployment
      • 5.5.4.8 Solutions
      • 5.5.4.9 Mode
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Technology
      • 5.5.5.4 Component
      • 5.5.5.5 Application
      • 5.5.5.6 End User
      • 5.5.5.7 Deployment
      • 5.5.5.8 Solutions
      • 5.5.5.9 Mode
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Technology
      • 5.5.6.4 Component
      • 5.5.6.5 Application
      • 5.5.6.6 End User
      • 5.5.6.7 Deployment
      • 5.5.6.8 Solutions
      • 5.5.6.9 Mode
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Technology
      • 5.6.1.4 Component
      • 5.6.1.5 Application
      • 5.6.1.6 End User
      • 5.6.1.7 Deployment
      • 5.6.1.8 Solutions
      • 5.6.1.9 Mode
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Technology
      • 5.6.2.4 Component
      • 5.6.2.5 Application
      • 5.6.2.6 End User
      • 5.6.2.7 Deployment
      • 5.6.2.8 Solutions
      • 5.6.2.9 Mode
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Technology
      • 5.6.3.4 Component
      • 5.6.3.5 Application
      • 5.6.3.6 End User
      • 5.6.3.7 Deployment
      • 5.6.3.8 Solutions
      • 5.6.3.9 Mode
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Technology
      • 5.6.4.4 Component
      • 5.6.4.5 Application
      • 5.6.4.6 End User
      • 5.6.4.7 Deployment
      • 5.6.4.8 Solutions
      • 5.6.4.9 Mode
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Technology
      • 5.6.5.4 Component
      • 5.6.5.5 Application
      • 5.6.5.6 End User
      • 5.6.5.7 Deployment
      • 5.6.5.8 Solutions
      • 5.6.5.9 Mode

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 IBM
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Microsoft
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Google
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Amazon
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Siemens Healthineers
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Philips Healthcare
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 GE Healthcare
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Medtronic
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Cerner Corporation
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Epic Systems Corporation
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 NVIDIA
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Intel Corporation
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Nuance Communications
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Allscripts Healthcare Solutions
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Zebra Medical Vision
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 iCarbonX
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Tempus Labs
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 PathAI
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Butterfly Network
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Viz.ai
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us